Friday, 23 June 2017

Sentinel Lymph Node Mapping and Dissection in Patients with Endometrial Cancer

Endometrial Cancer

In developed countries, endometrial cancer (EC) is the most frequent cancer of the female reproductive system.

According to the recent recommendations and guidelines, systematic surgical staging represents the primary treatment of these patients.

However, the extent of this procedure should be carefully individualized according to the histological type and the patient’s general performance status.

Thursday, 22 June 2017

Personalized Medicine is the Key to Effective Cancer Treatment

Personalized Medicine
Cancer is a disease involving abnormal cell growth with the potential to invade or metastasize to other parts of the body. The most common types of cancer in males are lung cancer, prostate cancer, colorectal cancer, and stomach cancer, and in females, the most common types are breast cancer, colorectal cancer, lung cancer, and cervical cancer.

In children, acute lymphoblastic leukemia and brain tumors are the most common types of cancer.

The risk of cancer increases significantly with age in addition to the many other risk factors such as the use of tobacco, obesity, lack of physical activity, environmental pollutants, viruses and many others.

Tuesday, 20 June 2017

FG-3019, A Human Monoclonal Antibody to Connective Tissue Growth Factor, Combined with Chemotherapy in Patients with Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

Human Monoclonal Antibody
Connective tissue growth factor (CTGF) is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and facilitates local desmoplasia, tumor progression and metastasis in animal models.

This study evaluated safety and initial efficacy of the anti-CTGF antibody FG-3019 in combination with gemcitabine and erlotinib in patients with previously untreated Stage III or Stage IV PDAC.

Eight escalating FG-3019 doses/regimens ranging from 3 to 45 mg/kg Q2W and 17.5 and 22.5 mg/kg QW were evaluated. Toxicity, tumor response by CA19.9 and CT scan RECIST criteria, progression-free and overall survival were assessed.

Monday, 19 June 2017

Childhood Cancer Care in Developing Countries; Challenge

Childhood Cancer Care
Dealing with children who have cancer in developing countries is a great human experience not only for the patient and the family but also for persons who are caring them.

The diagnosis of a child as a cancer case is really a great shock to all family members and it is a moment of a dramatic change in their life. First reaction is usually a combination of sadness and denial.

They will start a new style of life with a plenty of investigations, appointments and different treatments decisions and plans. Different negative emotional reactions are the classic feelings of the parents every time they meet the treating physician.

Friday, 16 June 2017

Medico-legal Aspects of Delay in Diagnosis of Breast Cancer

Diagnosis of Breast Cancer
As a capricious and heterogeneous disease breast cancer may be difficult to diagnose and despite being appropriately treated may relapse unexpectedly.

Governmental pressure to reduce waiting for women with breast cancer may lead some patients to suspect that very short delays may impact adversely on their prognosis. In this supercharged atmosphere of anxiety, communicational skills of breast surgeons may be constantly tested so that minor solecisms may translate into major patient dissatisfaction.

With this background it is unsurprising that more patients are turning to litigation in an attempt to obtain satisfaction for what they perceive as medical negligence.

Wednesday, 14 June 2017

Review of Leakage from a Linear Accelerator and Its Side Effects on Cancer Patients

Linear Accelerator
Radiation therapy using external beam radiation therapy (EBRT) is playing an important role for effective treatment of all kinds of tumors.

Peripheral dose is the result of leakage and scatter from multileaf collimators devices (MLCs), counts for 2-10% of the maximum dose given to the patient, depending on the machine used and type of treatment.

The present review reveals that despite of the recent advancements in linear accelerators (LINAC) and MLC design and technology, the remaining small amount of leakage (peripheral dose) of these devices still has significant side effects on patient’s life span and quality of life after treatment.

Monday, 12 June 2017

Squamous cell carcinomas (SCC) are second most common cutaneous malignancy. Exposure to ultraviolet rays remains the single most important etiological factor.
Cell Carcinoma

Although SCC can arise in unexposed areas these are typically associated with long standing ulcers and sinuses or immunosuppression. There are no randomized controlled trials on primary cutaneous SCC in general and in these rare subsites in particular.

There is no consensus on the management of these tumours particularly the role of prophylactic lymph node dissection and role of adjuvant radiotherapy.